Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Neuphoria Therapeutics (NEUP) Operating Margin (2024 - 2025)

Neuphoria Therapeutics (NEUP) has disclosed Operating Margin for 2 consecutive years, with 36797.58% as the latest value for Q2 2025.

  • Quarterly Operating Margin changed N/A to 36797.58% in Q2 2025 from the year-ago period, while the trailing twelve-month figure was 17.47% through Dec 2025, changed N/A year-over-year, with the annual reading at 1.12% for FY2025, N/A changed from the prior year.
  • Operating Margin for Q2 2025 was 36797.58% at Neuphoria Therapeutics, up from 79.85% in the prior quarter.
  • The five-year high for Operating Margin was 36797.58% in Q2 2025, with the low at 558.84% in Q4 2024.